Commitments and Contingencies (Details Narrative)
|
|
|
3 Months Ended |
|
|
Nov. 03, 2020 |
Dec. 13, 2019
USD ($)
$ / shares
shares
|
Dec. 13, 2019
EUR (€)
shares
|
Mar. 31, 2022
USD ($)
|
Mar. 31, 2022
EUR (€)
|
Mar. 31, 2022
EUR (€)
|
Dec. 31, 2021
USD ($)
|
Initial Rent, In Month |
|
|
|
$ 7,642
|
|
|
|
Right Of Use Assets In Exchange For Right Of Use Liabilities |
|
|
|
461,341
|
|
|
|
Payable By Company For Services Rendered |
|
|
|
9,588
|
|
|
|
Stock Option Expenses |
|
|
|
803,207
|
|
|
|
Payments For Future Research And Collobration |
|
|
|
767,678
|
|
|
|
Aggerate Amount Payable, Description |
the Company to pay in aggregate of up to $2.9 million over a period of 22 months
|
|
|
|
|
|
|
Long Term Debt Payable |
|
|
|
3,365,191
|
|
|
|
Grant Repyable |
|
|
|
289,006
|
|
|
|
Operating Lease Right-of-use Assets |
|
|
|
830,257
|
|
|
$ 383,551
|
Operating Lease Liabilities |
|
|
|
843,443
|
|
|
|
Short Term Lease Costs |
|
|
|
20,854
|
|
|
|
Finance Lease Obligations [Member] |
|
|
|
|
|
|
|
Lease Payable |
|
|
|
604,242
|
|
|
|
Operating Lease Right of Use Obligations [Member] |
|
|
|
|
|
|
|
Operating Lease Liabilities |
|
|
|
$ 881,024
|
|
|
|
Weighted Average Discount Rate |
|
|
|
2.45%
|
|
2.45%
|
|
Weighted Average Remaining Lease Term |
|
|
|
35 years
|
35 years
|
|
|
Payment Of Lease Liabilities |
|
|
|
$ 55,975
|
|
|
|
Operating Lease Expense |
|
|
|
72,865
|
|
|
|
Stock Incentive Plan [Member] |
|
|
|
|
|
|
|
Stock Option Expenses |
|
|
|
941,848
|
|
|
|
Restricted Stock |
|
|
|
500,000
|
|
|
|
Total Of Stock Option |
|
|
|
1,000,000
|
|
|
|
Managing Director's Agreement [Member] |
|
|
|
|
|
|
|
Amount Payable |
|
|
|
217
|
|
|
|
Royalty Payment |
|
|
|
$ 134,217
|
|
|
|
Royality |
|
|
|
6.00%
|
6.00%
|
|
|
Payable In Equal Monthly Installments | € |
|
|
|
|
|
€ 288,000
|
|
Stock Based Compensation Expenses |
|
|
|
$ 753,000
|
|
|
|
August 2021 [Member] |
|
|
|
|
|
|
|
Compensation Expenses |
|
|
|
805,840
|
|
|
|
Accrued Compensation |
|
|
|
601,000
|
|
|
|
In 2018 [Member] | Walloon Region Government [Member] | Colorectal Cancer Research Agreement [Member] |
|
|
|
|
|
|
|
Amount Repayable |
|
|
|
$ 119,102
|
|
|
|
Terms Of Agreement Description |
|
|
|
it is due to pay a 3.53% royalty on such revenue to the Walloon Region. The maximum amount payable to the Walloon Region, in respect of the aggregate of the amount repayable of €181,500 and the 3.53% royalty on revenue, is equal to the amount of funding received
|
it is due to pay a 3.53% royalty on such revenue to the Walloon Region. The maximum amount payable to the Walloon Region, in respect of the aggregate of the amount repayable of €181,500 and the 3.53% royalty on revenue, is equal to the amount of funding received
|
|
|
Repayment Of Grants | € |
|
|
|
|
|
181,500
|
|
Royality On Revenue |
|
|
|
3.53%
|
3.53%
|
|
|
Grant Receivable | € |
|
|
|
|
|
605,000
|
|
Grant Repaid By Installments |
|
|
|
over 12 years
|
over 12 years
|
|
|
In 2018 [Member] | BNP Paribas leasing solutions [Member] | Finance Lease Obligations [Member] |
|
|
|
|
|
|
|
Amount Payable |
|
|
|
$ 0
|
|
|
|
Purchase Price For The Property | € |
|
|
|
|
|
€ 25,000
|
|
Maturity Date |
|
|
|
January 2022
|
January 2022
|
|
|
Implicit Interest |
|
|
|
1.35%
|
|
1.35%
|
|
Leased Equipment Amortized Term |
|
|
|
5 years
|
5 years
|
|
|
In 2018 [Member] | Clinical Study Research Agreement [Member] | University of Taiwan [Member] |
|
|
|
|
|
|
|
Collaborative Obligations Amount Due |
|
|
|
$ 510,000
|
|
|
|
Lease Agreement Expire Period |
|
|
|
three-year
|
three-year
|
|
|
Collaborative Obligations Amount |
|
|
|
$ 2,550,000
|
|
|
|
In 2010 [Member] | Walloon Region Government [Member] |
|
|
|
|
|
|
|
Amount Repayable |
|
|
|
$ 61,026
|
|
|
|
Terms Of Agreement Description |
|
|
|
it is due to pay a 6% royalty on such revenue to the Walloon Region. The maximum amount payable to the Walloon Region, in respect of the aggregate of the amount repayable of €314,406 and the 6% royalty on revenue, is equal to twice the amount of funding received
|
it is due to pay a 6% royalty on such revenue to the Walloon Region. The maximum amount payable to the Walloon Region, in respect of the aggregate of the amount repayable of €314,406 and the 6% royalty on revenue, is equal to twice the amount of funding received
|
|
|
Repayment Of Grants | € |
|
|
|
|
|
€ 314,406
|
|
Royality On Revenue |
|
|
|
6.00%
|
6.00%
|
|
|
Grant Receivable | € |
|
|
|
|
|
1,050,000.00
|
|
In 2020 [Member] | Walloon Region Government [Member] |
|
|
|
|
|
|
|
Amount Repayable |
|
|
|
$ 57,348
|
|
|
|
Terms Of Agreement Description |
|
|
|
it is due to pay a 2.89% royalty on such revenue to the Walloon Region. The maximum amount payable to the Walloon Region, in respect of the aggregate of the amount repayable of €148,500 and the 2.89% royalty on revenue, is equal to the amount of funding received
|
it is due to pay a 2.89% royalty on such revenue to the Walloon Region. The maximum amount payable to the Walloon Region, in respect of the aggregate of the amount repayable of €148,500 and the 2.89% royalty on revenue, is equal to the amount of funding received
|
|
|
Repayment Of Grants | € |
|
|
|
|
|
148,500
|
|
Royality On Revenue |
|
|
|
2.89%
|
2.89%
|
|
|
Grant Receivable | € |
|
|
|
|
|
495,000
|
|
Grant Repaid By Installments |
|
|
|
over 10 years
|
over 10 years
|
|
|
In 2020 [Member] | Walloon Region Government [Member] | Colorectal Cancer Research Agreement [Member] |
|
|
|
|
|
|
|
Amount Repayable |
|
|
|
$ 51,530
|
|
|
|
Terms Of Agreement Description |
|
|
|
it is due to pay a 4.34% royalty on such revenue to the Walloon Region. The maximum amount payable to the Walloon Region, in respect of the aggregate of the amount repayable of €278,830 and the 4.34% royalty on revenue, is equal to the amount of funding received
|
it is due to pay a 4.34% royalty on such revenue to the Walloon Region. The maximum amount payable to the Walloon Region, in respect of the aggregate of the amount repayable of €278,830 and the 4.34% royalty on revenue, is equal to the amount of funding received
|
|
|
Repayment Of Grants | € |
|
|
|
|
|
278,830
|
|
Royality On Revenue |
|
|
|
4.34%
|
4.34%
|
|
|
Grant Receivable | € |
|
|
|
|
|
929,433
|
|
Grant Repaid By Installments |
|
|
|
over 15 years
|
over 15 years
|
|
|
In 2016 [Member] | ING [Member] | Long-term Debt [Member] |
|
|
|
|
|
|
|
Purchase Price For The Property | € |
|
|
|
|
|
€ 1,120,000
|
|
Maturity Date |
|
|
|
May 2031
|
May 2031
|
|
|
Fixed Interest Rate On Lease |
|
|
|
2.62%
|
|
2.62%
|
|
Lease Payable |
|
|
|
$ 533,346
|
|
|
|
In 2016 [Member] | Loan Agreement [Member] | ING [Member] | Long-term Debt [Member] |
|
|
|
|
|
|
|
Maturity Date |
|
|
|
December 2031
|
December 2031
|
|
|
Fixed Interest Rate |
|
|
|
2.62%
|
|
2.62%
|
|
Repayment Of Long-term Loan Amount | € |
|
|
|
|
€ 270,000
|
|
|
Principal Balance Payable |
|
|
|
$ 209,267
|
|
|
|
Loan Agreement Term |
|
|
|
15 years
|
15 years
|
|
|
In 2016 [Member] | Loan Agreement [Member] | Namur Invest [Member] | Long-term Debt [Member] |
|
|
|
|
|
|
|
Maturity Date |
|
|
|
December 2023
|
December 2023
|
|
|
Fixed Interest Rate |
|
|
|
4.85%
|
|
4.85%
|
|
Repayment Of Long-term Loan Amount | € |
|
|
|
|
€ 440,000
|
|
|
Loan Agreement Term |
|
|
|
7 years
|
7 years
|
|
|
Total Long-term Debt |
|
|
|
$ 146,891
|
|
|
|
In 2016 [Member] | Research Co-operation Agreement [Member] | DKFZ [Member] |
|
|
|
|
|
|
|
Collaborative Obligations Amount Due |
|
|
|
$ 221,913
|
|
|
|
Lease Agreement Expire Period |
|
|
|
five-year
|
five-year
|
|
|
Collaborative Obligations Amount | € |
|
|
|
|
|
€ 400,000
|
|
February 5, 2022 [Member] | Loan Agreement [Member] | First Insurance Funding [Member] | Long-term Debt [Member] |
|
|
|
|
|
|
|
Maturity Date |
|
|
|
November 2022
|
November 2022
|
|
|
Fixed Interest Rate |
|
|
|
3.57%
|
|
3.57%
|
|
Repayment Of Long-term Loan Amount | € |
|
|
|
|
€ 620,549
|
|
|
Loan Agreement Term |
|
|
|
9 years
|
9 years
|
|
|
Total Long-term Debt |
|
|
|
$ 551,599
|
|
|
|
Agreement Under Amount | € |
|
|
|
|
€ 620,549
|
|
|
November 23, 2021 [Member] | Loan Agreement [Member] | SOFINEX [Member] | Long-term Debt [Member] |
|
|
|
|
|
|
|
Maturity Date |
|
|
|
June 2025
|
June 2025
|
|
|
Fixed Interest Rate |
|
|
|
5.00%
|
|
5.00%
|
|
Repayment Of Long-term Loan Amount | € |
|
|
|
|
€ 450,000
|
|
|
Loan Agreement Term |
|
|
|
3 years 5 months 30 days
|
3 years 5 months 30 days
|
|
|
Total Long-term Debt |
|
|
|
$ 499,304
|
|
|
|
Agreement Under Amount | € |
|
|
|
|
€ 450,000
|
|
|
In 2017 [Member] | Loan Agreement [Member] | SOFINEX [Member] | Long-term Debt [Member] |
|
|
|
|
|
|
|
Maturity Date |
|
|
|
September 2024
|
September 2024
|
|
|
Fixed Interest Rate |
|
|
|
4.50%
|
|
4.50%
|
|
Repayment Of Long-term Loan Amount | € |
|
|
|
|
€ 1,000,000
|
|
|
Loan Agreement Term |
|
|
|
7 years
|
7 years
|
|
|
Total Long-term Debt |
|
|
|
$ 665,738
|
|
|
|
In 2018 [Member] | Loan Agreement [Member] | Namur Innovation and Growth [Member] | Long-term Debt [Member] |
|
|
|
|
|
|
|
Maturity Date |
|
|
|
June 2022
|
June 2022
|
|
|
Fixed Interest Rate |
|
|
|
4.00%
|
|
4.00%
|
|
Repayment Of Long-term Loan Amount | € |
|
|
|
|
€ 500,000
|
|
|
Loan Agreement Term |
|
|
|
4 years
|
4 years
|
|
|
Total Long-term Debt |
|
|
|
$ 42,250
|
|
|
|
In 2019 [Member] | Loan Agreement [Member] | Namur Invest [Member] | Long-term Debt [Member] |
|
|
|
|
|
|
|
Maturity Date |
|
|
|
September 2024
|
September 2024
|
|
|
Fixed Interest Rate |
|
|
|
4.80%
|
|
4.80%
|
|
Repayment Of Long-term Loan Amount | € |
|
|
|
|
€ 500,000
|
|
|
Loan Agreement Term |
|
|
|
4 years
|
4 years
|
|
|
Total Long-term Debt |
|
|
|
$ 405,646
|
|
|
|
October 13, 2020 [Member] | Loan Agreement [Member] | Namur [Member] | Long-term Debt [Member] |
|
|
|
|
|
|
|
Maturity Date |
|
|
|
March 2031
|
March 2031
|
|
|
Fixed Interest Rate |
|
|
|
4.00%
|
|
4.00%
|
|
Repayment Of Long-term Loan Amount | € |
|
|
|
|
€ 830,000
|
|
|
Loan Agreement Term |
|
|
|
10 years
|
10 years
|
|
|
Total Long-term Debt |
|
|
|
$ 844,496
|
|
|
|
On September 16, 2020 [Member] | Bioinformatic Analytics Of Cell Free DNA [Member] |
|
|
|
|
|
|
|
Repayment Of Long-term Loan Amount | € |
|
|
|
|
€ 54,879
|
|
|
Total Long-term Debt |
|
|
|
16,771
|
|
|
|
Additional Cost Of Company | € |
|
|
|
|
€ 155,115
|
|
|
In 2019 [Member] | Collaborative Arrangement, Co-promotion [Member] |
|
|
|
|
|
|
|
Collaborative Obligations Amount Due |
|
|
|
$ 18,994
|
|
|
|
Lease Agreement Expire Period |
|
|
|
five-year
|
five-year
|
|
|
Collaborative Obligations Amount |
|
|
|
$ 400,000
|
|
|
|
Research Collaboration Agreement Description |
|
|
|
Company entered into a funded sponsored research agreement with the Texas A&M University (“TAMU”) in consideration for the license granted to the Company for a five-year period for a cost to the Company of up to $400,000 payable over such period
|
Company entered into a funded sponsored research agreement with the Texas A&M University (“TAMU”) in consideration for the license granted to the Company for a five-year period for a cost to the Company of up to $400,000 payable over such period
|
|
|
October 25, 2019 [Member] | TAMU [Member] |
|
|
|
|
|
|
|
Non-controlling Interest |
|
|
|
7.50%
|
7.50%
|
|
|
Equity Interest |
|
|
|
12.50%
|
12.50%
|
|
|
Additional Interest |
|
|
|
5.00%
|
5.00%
|
|
|
January 10, 2020 [Member] |
|
|
|
|
|
|
|
Agrrement Liability |
|
$ 6,535
|
|
|
|
|
|
Common Stock, Restricted Shares Issued In Exchange Of Purchased Outstanding Shares, Value |
|
$ 333,969
|
|
|
|
|
|
Restricted Shares Issued | shares |
|
73,263
|
73,263
|
|
|
|
|
Common Stock, Restricted Shares Issued In Exchange Of Purchased Outstanding Shares, Shares | shares |
|
73,263
|
73,263
|
|
|
|
|
Weighted Trading Price Per Share | $ / shares |
|
$ 4.56
|
|
|
|
|
|
Repayment Of Debt | € |
|
|
€ 350,000
|
|
|
|
|
Common Stock Adjusted Amount |
|
$ 357,000
|
|
|
|
|
|
Holdback Period |
|
|
|
9 years
|
9 years
|
|
|
Holdback Liabilities |
|
|
|
$ 55,404
|
|
|
|
Net Liabilities |
|
$ 43,152
|
|
|
|
|
|